Journal article · 2026

Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases

Mingyuan Sun, Yingfeng Huang, Ruixia Zhang, Zhen Jing, Xiaofang Zhang, Yuchao Wei, Junyuan Qi

Cancer Research, 86(7_Supplement), 5389 · Published 3 April 2026 · DOI 10.1158/1538-7445.am2026-5389

View at the publisherCite this paper

In brief

“Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases” is a 2026 journal article by Mingyuan Sun and 6 co-authors, published in Cancer Research. OpenAlex counts 1 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Authors
7

Abstract

Background: CD19-targeted T cell engagers (TCEs) have the potential to induce B-cell depletion with potential better safety than CAR-T therapy and off-the-shelf convenience. However, T cell dysfunction and exhaustion contribute to treatment failure following anti-CD19 bispecific TCE. In this study, we developed CC312, a novel tri-specific TCE that integrates CD28 co-stimulation with CD3 and CD19… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sun, M., Huang, Y., Zhang, R., Jing, Z., Zhang, X., Wei, Y., & Qi, J. (2026). Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases. Cancer Research, 86(7_Supplement), 5389. https://doi.org/10.1158/1538-7445.am2026-5389

MLA 9

Sun, Mingyuan, et al. “Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases.” Cancer Research, vol. 86, no. 7_Supplement, 2026, p. 5389. https://doi.org/10.1158/1538-7445.am2026-5389.

Chicago

Sun, Mingyuan, Yingfeng Huang, Ruixia Zhang, Zhen Jing, Xiaofang Zhang, Yuchao Wei, and Junyuan Qi. 2026. “Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases.” Cancer Research 86 (7_Supplement): 5389. https://doi.org/10.1158/1538-7445.am2026-5389.

Harvard

Sun, M. et al. (2026) ‘Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases’, Cancer Research, 86(7_Supplement), p. 5389. doi:10.1158/1538-7445.am2026-5389.

IEEE

M. Sun et al., “Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases,” Cancer Research, vol. 86, no. 7_Supplement, p. 5389, 2026, doi: 10.1158/1538-7445.am2026-5389.

BibTeX

@article{sun2026abstract,
  title     = {{Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases}},
  author    = {Sun, Mingyuan and Huang, Yingfeng and Zhang, Ruixia and Jing, Zhen and Zhang, Xiaofang and Wei, Yuchao and Qi, Junyuan},
  journal   = {Cancer Research},
  year      = {2026},
  volume    = {86},
  number    = {7_Supplement},
  pages     = {5389},
  doi       = {10.1158/1538-7445.am2026-5389},
  url       = {https://doi.org/10.1158/1538-7445.am2026-5389}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research

  • CD19
  • CD3
  • CD28 costimulation
  • B-cell depletion
  • systemic lupus erythematosus
  • refractory autoimmune disease
  • maximum tolerated dose
  • cytokine release syndrome

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Sun, M., Huang, Y., Zhang, R., Jing, Z., Zhang, X., Wei, Y., & Qi, J. (2026). Abstract 5389: CC312, a novel CD19/CD3/CD28 tri-specific T cell engager, leads to rapid and deep B-cell depletion and has broad potential for development in autoimmune diseases. Cancer Research, 86(7_Supplement), 5389. https://doi.org/10.1158/1538-7445.am2026-5389

How many times has this paper been cited?

1 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mingyuan Sun, Yingfeng Huang, Ruixia Zhang, Zhen Jing, Xiaofang Zhang, Yuchao Wei, Junyuan Qi.

What is the DOI of this paper?

10.1158/1538-7445.am2026-5389, permanently at https://doi.org/10.1158/1538-7445.am2026-5389. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.